Patents-Review.com
ClassID:

92924 ⎘

C07C243/38 - CPC Classification

Classification description:

Compounds containing chains of nitrogen atoms singly-bound to each other, e.g. hydrazines, triazanes; Hydrazines having nitrogen atoms of hydrazine groups acylated by carboxylic acids with acylating carboxyl groups bound to carbon atoms of six-membered aromatic rings

Recent Application in this class:
#1
20260041683
2026-02-12

Compounds with Anti-Acinetobacter Baumannii Activity

 #2
20250197537
2025-06-19

COMPOUND, CURABLE RESIN COMPOSITION, CURED PRODUCT, AND DECOMPOSITION METHOD

 #3
20240180916
2024-06-06

Theramutein modultors

 #4
20240043395
2024-02-08

COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING

 #5
20240018169
2024-01-18

COMPOSITIONS AND METHODS FOR INHIBITING GROUP II INTRON RNA

 #6
20230174470
2023-06-08

COMPOUND AS A UBR BOX DOMAIN LIGAND

 #7
20230174465
2023-06-08

COMPOUND AS A UBR BOX DOMAIN LIGAND

 #8
20230127630
2023-04-27

IGF2BP2 INHIBITORS AND USES THEREOF

 #9
20230022116
2023-01-26

Crystals and production method for the same

 #10
20220370469
2022-11-24

Theramutein modulators

 #11
20220362257
2022-11-17

Theramutein modulators

 #12
20210163424
2021-06-03

Eco-friendly materials and methods for renewable and sustainable applications in material chemistry

 #13
20210161144
2021-06-03

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

 #14
20210139512
2021-05-13

Compositions and methods for inhibiting group II intron RNA

 #15
20210108048
2021-04-15

Additive for rubber, rubber composition, and tire using the same

 #16
20210078937
2021-03-18

Benzoannulene derivatives as antiviral agents

 #17
20210015825
2021-01-21

Theramutein modulators

 #18
20210009509
2021-01-14

HDAC inhibitor compounds and methods of treatment

 #19
20210008077
2021-01-14

Theramutein modulators

 #20
20200270225
2020-08-27

Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex

 #21
20200102264
2020-04-02

MARMELIN ANALOGS AND METHODS OF USE IN CANCER TREATMENT

 #22
20200048188
2020-02-13

CRYSTALLINE DIACYLHYDRAZINE AND THE USE THEREOF

 #23
20200046718
2020-02-13

Theramutein modulators

 #24
20190309013
2019-10-10

Linker molecule and use thereof in methods for purifying peptides

 #25
20190308932
2019-10-10

Histone deacetylase inhibitors and uses thereof

 #26
20190177513
2019-06-13

Rubber composition, tire, additive and hydrazide compound

 #27
20190166847
2019-06-06

Molecules having pesticidal utility, and intermediates, compositions, and processes related thereto

 #28
20190150452
2019-05-23

MOLECULES HAVEING PESTICIDAL UTILIY AND INTERMEDIATES, COMPOSITIONS AND PROCESSES RELATED THERETO

 #29
20190047965
2019-02-14

Eco-friendly materials and methods for renewable and sustainable applications in material chemistry

 #30
20180362449
2018-12-20

THE EXOCYST AS A NOVEL DRUG TARGET OF ENDOSIDIN2 AND APPLICATION AS A THERAPEUTIC

 #31
20180273469
2018-09-27

MARMELIN ANALOGS AND METHODS OF USE IN CANCER TREATMENT

 #32
20180215677
2018-08-02

5,5′-bis(2,4,6-Trinitrophenyl)-2,2′-bi(1,3,4-oxadiazole) and bis(2,4,6-trinitrobenzoyl)oxalohydrazide

 #33
20180194718
2018-07-12

Neprilysin inhibitors

 #34
20180098541
2018-04-12

Molecules having pesticidal utility and intermediates, compositions and processes related thereto

 #35
20180042935
2018-02-15

Theramutein modulators

 #36
20170340757
2017-11-30

Targeted contrast agents comprising a hydrazide functional group

 #37
20170327459
2017-11-16

Neprilysin inhibitors

 #38
20170267630
2017-09-21

Class-and isoform-specific HDAC inhibitors and uses thereof

 #39
20170208810
2017-07-27

Molecules having pesticidal utility, and intermediates, compositions, and processes, related thereto

 #40
20170204079
2017-07-20

Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

 #41
20170174619
2017-06-22

HDAC inhibitor compounds and methods of treatment

 #42
20170158675
2017-06-08

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

 #43
20170158674
2017-06-08

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

 #44
20170156320
2017-06-08

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

 #45
20170144965
2017-05-25

MARMELIN ANALOGS AND METHODS OF USE IN CANCER TREATMENT

 #46
20170107175
2017-04-20

Crystalline diacylhydrazine and the use thereof

 #47
20170015619
2017-01-19

Neprilysin inhibitors

 #48
20160192651
2016-07-07

Pesticide

 #49
20160083403
2016-03-24

Boron-containing diacylhydrazine compounds

 #50
20160052871
2016-02-25

Curing agents and degradable polymers and composites based thereon

 #51
20160044925
2016-02-18

Pesticidal compositions and processes related thereto

 #52
20160044919
2016-02-18

Pesticidal compositions and processes related thereto

 #53
20160037779
2016-02-11

Pesticidal compositions and processes related thereto

 #54
20160029636
2016-02-04

Pesticidal compositions and processes related thereto

 #55
20150376128
2015-12-31

Neprilysin inhibitors

 #56
20150353477
2015-12-10

Pesticidal compositions and processes related thereto

 #57
20150307444
2015-10-29

Class- and isoform-specific HDAC inhibitors and uses thereof

 #58
20150266810
2015-09-24

COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION

 #59
20150252043
2015-09-10

Hematopoietic growth factor mimetic small molecule compounds and their uses

 #60
20150202240
2015-07-23

Compositions and methods for enhancing virus efficacy

 #61
20150191445
2015-07-09

ACYL-HYDRAZONE AND OXADIAZOLE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND USES THEREOF

 #62
20150133441
2015-05-14

Theramutein modulators

 #63
20150099636
2015-04-09

Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

 #64
20150045441
2015-02-12

Crystalline diacylhydrazine and the use thereof

 #65
20150005256
2015-01-01

Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex

 #66
20140357894
2014-12-04

Visual detection of fluoride ions

 #67
20140315959
2014-10-23

Treatment of ovarian cancer with benzylidenebenzohydrazides

 #68
20140243324
2014-08-28

USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS

 #69
20140206537
2014-07-24

Pesticidal compositions and processes related thereto

 #70
20140171315
2014-06-19

Pesticidal compositions and processes related thereto

 #71
20140171314
2014-06-19

Pesticidal compositions and processes related thereto

 #72
20140171311
2014-06-19

Pesticidal compositions and processes related thereto

 #73
20140171310
2014-06-19

Pesticidal compositions and processes related thereto

 #74
20140045903
2014-02-13

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

 #75
20140031230
2014-01-30

Auxin biosynthesis inhibitor

 #76
20130344608
2013-12-26

Visual detection of fluoride ions

 #77
20130296557
2013-11-07

Diarylacetylene hydrazide containing tyrosine kinase inhibitors

 #78
20130150358
2013-06-13

THERAMUTEIN MODULATORS

 #79
20130079413
2013-03-28

Crystalline diacylhydrazine and the use thereof

 #80
20130040389
2013-02-14

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

 #81
20130035487
2013-02-07

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

 #82
20120329649
2012-12-27

PESTICIDAL COMPOSITIONS AND PROCESSES RELATED THERETO

 #83
20120322878
2012-12-20

Polycationic compounds and uses thereof

 #84
20120316066
2012-12-13

Process of preparing chiral diacylhydrazine ligands

 #85
20120295904
2012-11-22

Hematopoietic growth factor mimetic small molecule compounds and their uses

 #86
20120208889
2012-08-16

Class- and isoform-specific HDAC inhibitors and uses thereof

 #87
20120134963
2012-05-31

Compositions and methods for enhancing virus efficacy

 #88
20120116090
2012-05-10

Chiral Diacylhydrazine Ligands for Modulating the Expression of Exogenous Genes via an Ecdysone Receptor Complex

 #89
20120094977
2012-04-19

Compositions and methods for the treatment of disease associated with TRP-P8 expression

 #90
20120046322
2012-02-23

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

 #91
20110224302
2011-09-15

Difluorophenyldiacylhydrazide derivatives

 #92
20110218353
2011-09-08

Fluorovinyl ether functionalized aromatic diesters, derivatives thereof, and process for the preparation thereof

 #93
20110189306
2011-08-04

COMPOUNDS, COMPOSITIONS AND TREATMENTS FOR V-ATPase RELATED DISEASES

 #94
20110124664
2011-05-26

Polycationic compounds and uses thereof

 #95
20110071125
2011-03-24

SUBSTITUTED PHENYLAMINO-BENZENE DERIVATIVES USEFUL FOR TREATING HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH MITOGEN EXTRACELLULAR KINASE ACTIVITY

 #96
20110060050
2011-03-10

SGK1 inhibitors for the prophylaxis and/or therapy of viral diseases and/or carcinomas

 #97
20110039819
2011-02-17

SUBSTITUTED PHENOXYBENZAMIDES

 #98
20110028463
2011-02-03

AMIDE COMPOUNDS

 #99
20100298344
2010-11-25

Polycationic compounds and uses thereof

 #100
20100179326
2010-07-15

Benzamide derivative

 #101
20100120866
2010-05-13

Process for producing amide compound

 #102
20100068139
2010-03-18

Methods of radiofluorination of biologically active vectors

 #103
20090324540
2009-12-31

Compounds and compositions for delivering active agents

 #104
20090239811
2009-09-24

Polycationic compounds and uses thereof

 #105
20090227649
2009-09-10

Management of Ophthalmologic Disorders, Including Macular Degeneration

 #106
20090221712
2009-09-03

Mandelic hydrazides

 #107
20090176837
2009-07-09

COMPOUNDS WITH ACTIVITY AT RETINOIC ACID RECEPTORS

 #108
20090163592
2009-06-25

Chiral diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

 #109
20090143592
2009-06-04

Glucagon Antagonists/Inverse Agonists

 #110
20090082328
2009-03-26

Substituted phenylamino-benzene derivatives useful for treating hyper-proliferative disorders and diseases associated with mitogen extracellular kinase activity

 #111
20090023926
2009-01-22

Trityl Derivatives for Enhancing Mass Spectrometry

 #112
20090023923
2009-01-22

1-3-bis(substituted phenyl)-3-hydroxypropan-1-one or 2-propen-1-one compound, and salt thereof

 #113
20080293711
2008-11-27

Chemokine receptor modulators

 #114
20080269324
2008-10-30

Management of Ophthalmologic Disorders, Including Macular Degeneration

 #115
20080269262
2008-10-30

Therameutin modulators

 #116
20080214627
2008-09-04

DIACYLHYDRAZINE LIGANDS FOR MODULATING THE EXPRESSION OF EXOGENOUS GENES IN MAMMALIAN SYSTEMS VIA AN ECDYSONE RECEPTOR COMPLEX

 #117
20080194521
2008-08-14

Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex

 #118
20080188678
2008-08-07

Near-infrared-absorbing organic electrochromic materials

 #119
20080167380
2008-07-10

Acyl hydrazines as kinase inhibitors, in particular for SGK

 #120
20080103113
2008-05-01

Diacylhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex

 #121
20080064741
2008-03-13

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

 #122
20080051374
2008-02-28

Therapeutic amides and related compounds

 #123
20070249050
2007-10-25

Substituted aromatic compounds for inflammation and immune-related uses

 #124
20070157846
2007-07-12

Antirust composition

 #125
20070142672
2007-06-21

Process for the allylation of n-acylhydrazones

 #126
20070123493
2007-05-31

Benzamide derivative

 #127
20070093529
2007-04-26

Diacylhydrazine derivatives

 #128
20070014721
2007-01-18

Hydrazide conjugates as imaging agents

 #129
20070004701
2007-01-04

Topoisomerase inhibitors

 #130
20060264673
2006-11-23

Copper-catalyzed formation of carbon-heteroatom and carbon—carbon bonds

 #131
20060258740
2006-11-16

Diacylglycerol acyltransferase inhibitors

 #132
20060235244
2006-10-19

Hydroxynaphthalenedicarboxylic acid hydrazide dimer and derivatives thereof as well as process for preparing them

 #133
20060235034
2006-10-19

Novel compounds for treatment of cancer and disorders associated with angiogenesis function

 #134
20060231589
2006-10-19

Hydroxynaphthalenedicarboxylic acid hydrazide and derivatives thereof as well as process for preparing them

 #135
20060173058
2006-08-03

KCNQ channel modulating compounds and their pharmaceutical use

 #136
20060166990
2006-07-27

Aminobenzophenone compounds

 #137
20060166859
2006-07-27

Compounds and compositions for delivering active agents

 #138
20060160812
2006-07-20

Methods for treating neural disorders and conditions, and compounds useful therefor

 #139
20060122428
2006-06-08

Hydroxynaphthoic acid hydrazide compound and method for preparing the same

 #140
20060111590
2006-05-25

Polymer-immobilized formamides, catalyst containing the same and allylation process

 #141
20060069078
2006-03-30

Management of ophthalmologic disorders, including macular degeneration

 #142
20060041024
2006-02-23

Polycationic compounds and uses thereof

 #143
20060020146
2006-01-26

Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex

 #144
20050215794
2005-09-29

Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds

 #145
20050209283
2005-09-22

Diaclhydrazine ligands for modulating the expression of exogenous genes in mammalian systems via an ecdysone receptor complex

 #146
20050203108
2005-09-15

Glucagon antagonists/inverse agonists

 #147
20050186176
2005-08-25

Compounds and compositions for delivering active agents

 #148
20050159415
2005-07-21

Agent for preventing/ameliorating obesity comprising methylidene hydrizide compound as active ingredient

 #149
20050148665
2005-07-07

Reagents and method for spatio-temporal control of gene expression by illumination

 #150
20050054651
2005-03-10

Compositions and methods for the treatment of disease associated with Trp-p8 expression